Swarajya
Our View
Magazine
Headlines
Videos
Books
स्वराज्य
Economy
Culture
Events
Subscribe
Swarajya
Subscribe
Our View
Headlines
Magazine
Swarajya
Politics
Economics
Business
Culture
Books & Ideas
World
Defence
Energy & Infrastructure
Science
Technology
Heritage
Videos
Archives
Blogs
News Brief
Subscriber login
Politics
Economics
Business
Culture
Books & Ideas
World
Defence
Energy & Infrastructure
Science
Technology
Heritage
Videos
Archives
Blogs
News Brief
DCGI
'Misleading, Fallacious': Government On Media Reports Claiming Covaxin Approval Was Rushed Due To Political Pressure
Swarajya Staff
Nov 17, 2022 02:09 PM +05:30 IST
Govt Panel Recommends Emergency Use Authorisation For Single-Dose 'Sputnik Light' Covid Vaccine
PTI
Feb 5, 2022 08:20 AM +05:30 IST
Full Market Approval For Covishield, Covaxin: DCGI Panel To Meet Again Soon To Review Proposals
Swarajya Staff
Jan 15, 2022 03:23 PM +05:30 IST
Serum Institute of India Seeks DCGI Nod For COVID-19 Vaccine COVOVAX
PTI
Oct 30, 2021 10:03 AM +05:30 IST
Bharat Biotech's Covaxin For Children To Get Approval For Emergency Use; Two Other Vaccines Are On The Pipeline
Bhaswati Guha Majumder
Oct 13, 2021 01:00 PM +05:30 IST
Hyderabad-Based Biological E Gets DCGI Nod To Conduct Phase 2/3 Clinical Trials Of Its COVID-19 Vaccine On Children
IANS
Sep 2, 2021 12:45 PM +05:30 IST
India's First mRNA COVID Vaccine Candidate Found To Be Safe, Gets DCGI Nod For Phase 2/3 Clinical Trials
Swarajya Staff
Aug 25, 2021 11:00 AM +05:30 IST
J&J Seeks Approval For Clinical Trials Of Its Single-Shot COVID-19 Vaccine On Adolescents Aged 12-17 Years In India
Swarajya Staff
Aug 20, 2021 01:06 PM +05:30 IST
DCGI Approves Study On Mixing Of Covaxin, Covishield Vaccines; Clinical Trial To Begin In Tamil Nadu's Vellore
Swarajya Staff
Aug 11, 2021 11:45 AM +05:30 IST
US Pharma Major J&J Seeks Emergency Use Approval For Its Single-Shot COVID-19 Vaccine In India
Swarajya Staff
Aug 6, 2021 04:14 PM +05:30 IST
Novavax Seeks DCGI's Approval For Emergency Use Of Its Covid-19 Vaccine In India
Swarajya Staff
Aug 6, 2021 09:29 AM +05:30 IST
DCGI's Expert Panel Gives Go-Ahead To Bharat Biotech For Mixing Of COVAXIN And Nasal COVID-19 Vaccine In Trials
Swarajya Staff
Jul 31, 2021 10:41 AM +05:30 IST
DCGI's Expert Panel To Take Up Zydus Cadila's Application For Emergency Use Approval To Its COVID-19 Jab This Week: Report
Swarajya Staff
Jul 7, 2021 11:42 AM +05:30 IST
DCGI's Expert Panel Says No To Covovax Trials On Children, Asks Serum Institute To Submit Safety Data First
Swarajya Staff
Jul 1, 2021 02:22 PM +05:30 IST
US-Based Moderna Seeks DCGI Approval For Its mRNA COVID-19 Vaccine In India: Report
Swarajya Staff
Jun 29, 2021 02:43 PM +05:30 IST
DCGI Approves Phase 2 Clinical Trial Of Repurposed Drug 'Colchicine' On COVID-19 Patients
Swarajya Staff
Jun 12, 2021 02:03 PM +05:30 IST
Serum Institute Seeks DCGI Nod For License To Manufacture Russian Sputnik V Covid-19 Vaccine In India
Swarajya Staff
Jun 3, 2021 01:04 PM +05:30 IST
DCGI Studying Use Of Alternate Drugs Other Than Amphotericin B To Treat Mucormycosis: Report
Swarajya Staff
Jun 2, 2021 12:01 PM +05:30 IST
India's Drug Regulator DCGI Exempts Local Bridging Trials For Foreign Vaccines Approved By WHO And Select Overseas Regulators
Swarajya Staff
Jun 2, 2021 11:01 AM +05:30 IST
Zydus Cadila Seeks DCGI's Approval For Conducting Clinical Trials Of Antibody Cocktail To Treat Mild COVID-19
Swarajya Staff
May 27, 2021 12:29 PM +05:30 IST
Load More